"PEGS-the essential protein engineering summit" continues its knowledge-sharing tradition in Boston

NEEDHAM, Mass. - Jan. 28, 2015 - PRLog -- This Spring, Cambridge Healthtech Institute (CHI) will return to Boston’s historic Seaport District to host its 11th Annual "PEGS - the essential protein engineering summit". Over 1,800 participants will convene for open forum discussions and collaboration in the areas of protein and antibody engineering, oncology, expression, analytical, immunogenicity, and therapeutics programming. The continued success of PEGS is driven by the growth in biologics worldwide, the quality of scientific programming, and valuable networking opportunities.

The summit is a weeklong event being held May 4-8 at The Seaport World Trade Center. A plenary keynote session will kick off the week with presentations from industry leaders Tillman Gerngross, Ph.D., CEO and Co-Founder of Adimab and Robert A. Weinberg, Ph.D., Founding Member of Whitehead Institute for Biomedical Research; Professor of Biology at Massachusetts Institute of Technology.

The summit will offer nearly 400 presentations within eight topic-focused streams comprised of 21 conferences, 15 short courses, over 100 exhibiting companies, and over 180 scientific research posters on display. Delegates can create their own agenda by moving between the tracks and choosing the sessions that best fit their research and networking needs. Conferences Programs Include:

ENGINEERING STREAM
Tools and Winning Strategies for Creating the Next Generation of Biologics
- Phage and Yeast Display of Antibodies
- Engineering Antibodies
- Engineering Bispecific Antibodies

ONCOLOGY STREAM
Learning from Recent Successes and Challenges to Advance Antibody Therapeutics
- Antibodies for Cancer Therapy
- Advancing Bispecific Antibodies & Combination Therapy to the Clinic
- ADCs: Preclinical and Clinical Updates

IMMUNOTHERAPY STREAM
Harnessing the Immune System for the Next Generation of Effective and Safe Therapeutics
- Biologics for Autoimmune Diseases
- Adoptive T Cell Therapy
- Agonist Immunotherapy Targets

EXPRESSION STREAM
Solving Problems in Protein Expression and Engineering
- Difficult to Express Proteins
- Optimizing Protein Expression
- Accelerating Cell Line & Cell Culture Development

ANALYTICAL STREAM
Overcoming Challenges in Characterization, Biophysical Analysis and Aggregation
- Characterization of Biotherapeutics
- Biophysical Analysis of Biotherapeutics
- Protein Aggregation and Stability in Biopharmaceuticals

IMMUNOGENICITY & BIOASSAYS STREAM
New Industry, Academic and Regulatory Case Studies and Updates for Safe and Efficacious Biotherapeutics
- Immunogenicity Prediction and Mitigation
- Immunogenicity Assessment & Clinical Relevance
- Bioassays for Biologics

BIOCONJUGATES STREAM
Delivering on the Promise of Bioconjugates: from Engineering to Therapeutics
- Fusion Protein Therapeutics
- Engineering ADCs
- ADCs: Preclinical and Clinical Updates

THERAPEUTICS STREAM
Advancing Non-Antibody Biologics with Novel Constructs and Next-Gen Engineering
- Fusion Protein Therapeutics
- Peptide Therapeutics

Important Dates:
Early registration discount deadline: February 13, 2015
Poster abstract submission deadline: March 27, 2015
Advanced registration discount deadline: March 27, 2015

To Register:
Call toll free: +1-888-999-6288
Visit: https://chidb.com/register/2015/pegs/reg.asp
For Group Discounts, contact David Cunningham, 781-972-5472, cunningham@healthtech.com.

Exhibit and sponsorship opportunities are available. For details, contact Carol Dinerstein, 781-972-5471, dinerstein@healthtech.com.

Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com.

For more information, visit http://www.PEGSummit.com.